Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III double-blind randomized comparison of cariprazine versus aripiprazole in adults with acute schizophrenia
CTR20241496Phase 3Active
- Sponsor
- Chengdu Kanghong Pharmaceutical Group
- Start
- May 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cariprazine, aripiprazole in schizophrenia, sponsored by Chengdu Kanghong Pharmaceutical Group. Started May 2024; status: active.
02
Drugs
cariprazinearipiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on CTR20241496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241496.